DalsnaFinance

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

Markets GlobeNewswire By GlobeNewswire 23 Jul 2026 13:15 1 min read
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

Deborah Ascheim, M.D., former Capricor Therapeutics CMO, elected to stem cell therapy company Longeveron (LGVN) Board of Directors.

Deborah Ascheim, M.D., former Capricor Therapeutics CMO, elected to stem cell therapy company Longeveron (LGVN) Board of Directors.

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.